Where is the COVID-19 Vaccine?

Where is the COVID-19 Vaccine?

Bayla Rothschild

Photo Creds: Insurance Journal

In recent weeks, two American companies, Pfizer and Moderna, have created vaccines for COVID-19. Both vaccines are reported to be over 90% effective and to have little to no side effects. The vaccines appear to work for people of all ages, regardless of where they live and the COVID-19 rates in their locations. 

One major concern about the Pfizer vaccine is its storage requirement. It needs to be stored at a temperature of negative seventy degrees celsius, which is even colder than winter in Antarctica. This will make distribution of the vaccine challenging, as hospitals and doctors’ offices do not have the facilities to store anything at that temperature. Special freezers will have to be purchased for the storage of the vaccine. The Moderna vaccine, on the other hand, has to be stored at a temperature of negative twenty degrees celsius, which is close to the temperature of a regular freezer. 

Both companies plan to submit their vaccine and vaccine studies to the FDA for approval in the coming weeks. If they get approved, people may be able to start getting vaccinated before the end of December. Pfizer and Moderna both claim that if their vaccine is approved by the FDA, they have the ability to produce and distribute vaccines in mass quantities fairly quickly.  It seems very likely that the first people to get vaccinated will be doctors and nurses, especially ones who deal directly with COVID-19 patients. It may take some time before the average person will get vaccinated, but it will likely happen during the coming spring, although earlier is possible. 

Once a COVID-19 vaccine begins to be distributed, the American economy will probably begin to recover. One important factor in the predicted economic recovery is the fact that the world will be, to some extent, dependent on an American vaccine. Both Pfizer and Moderna are American companies, and production of the vaccines will bring jobs and income to Americans, helping the economy to recover. Americans will also most likely be vaccinated before people in other countries, leading to a quicker decline in COVID-19 cases in the United States. Restrictions will be lifted, allowing Americans to return to work and stimulate the economy. In general, Americans will feel more positive and optimistic once the COVID-19 restrictions are eased and more people are protected by the vaccine. The very rapid development of the vaccine gives people hope that this hard, dark time will soon come to an end.